Skip to main navigation
Skip to search
Skip to main content
UNT Health Home
Search content at UNT Health
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
India
100%
COVID-19 Associated mucormycosis
100%
Mucormycosis
100%
Environmental Factors
66%
COVID-19
66%
Iatrogenic Factor
66%
CD8+ T Cells
33%
Biological Factors
33%
Glucose-regulated Protein 78 (GRP78)
33%
Fungal Pathogens
33%
Candida
33%
Two-hit
33%
COVID-19 in India
33%
Spleen Tyrosine Kinase
33%
Aspergillus
33%
Probable Cause
33%
Antifungal Defense
33%
Pneumocystis
33%
Invasive mucormycosis
33%
Dysglycemia
33%
Biochemistry, Genetics and Molecular Biology
Downregulation
100%
Upregulation
100%
Infectious Agent
100%
Candida
100%
CD8
100%
Janus Kinase 1
100%
Pneumocystis
100%
Aspergillus
100%
Immunology and Microbiology
COVID-19
100%
Infectious Agent
33%
Downregulation
33%
Upregulation
33%
CD8
33%
Candida
33%
Aspergillus
33%
Pneumocystis
33%
Tyrosine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Mucormycosis
100%
Disease Predisposition
20%
CD8 Antigen
20%
Antifungal Agent
20%
Infectious Agent
20%
Candida
20%
Aspergillus
20%
Pneumocystis
20%
Protein Kinase Syk
20%
Dysglycemia
20%
Janus Kinase 1
20%